The retrospective study analyzed SEER data from 2001 through 2009, and found that the annual CAD prevalence among Medicare screening mammograms increased from 3.5% to 79.7%.
When used during mammograms on women aged 65 and older, computer-aided detection (CAD) leads to more diagnostic intervention, including biopsy, and increases the detection of in situ breast tumors, a new study shows.
"Because in situ tumors often neither grow nor progress, CAD may be leading to a lot of unnecessary breast surgery and radiation in older women who don't really have ," Dr. Joshua J. Fenton, of the University of California Davis, told Reuters Health by email.
Medicare has reimbursed CAD during screening mammography since 2001. In a prior study, Dr. Fenton and colleagues found that CAD use increases the rate of false-positive findings on screening mammography and the detection of ductal carcinoma in situ (DCIS).
Complete report on Medscape: http://bit.ly/108L6LO
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
FDA Approves Danziten for Chronic Myeloid Leukemia Without Mealtime Restrictions
November 14th 2024The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase inhibitor for chronic myeloid leukemia that can be taken without mealtime restrictions.
Read More
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More